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Studying Human Fertility and
Environmental Exposures
In their review of approaches to studying the
influence of environmental exposures on
human fecundity, Tingen et al. (2004) com-
pared several ways of assessing fecundity.
Fecundity—the probability of pregnancy
in couples having regular intercourse without
contraception—can be assessed by applying
appropriate statistical approaches to time-to-
pregnancy (TTP) data. Tingen et al. (2004)
provided a thorough presentation of the
detailed prospective approach to assess TTP.
We agree that advantages of this approach,
in which daily urine samples are collected,
include allowing the estimation of the daily
probability of pregnancy within a menstrual
cycle and studying the early survival of the
embryo; however, we have reservations about
the authors’ conclusion that the detailed
prospective approach should be seen as the
gold standard for studying the effects of envi-
ronmental exposures on fecundity.
We believe that prospective TTP studies,
whether detailed or not, have one main limi-
tation, which lies in the difficulty of defining
precisely the target population: These studies
are often based on the inclusion of couples
soon planning to attempt conception or to
stop using contraceptive methods. In our
opinion, this population is ill-defined and
lacks a sampling frame, which makes the esti-
mation of participation rates difficult. Indeed,
many published detailed prospective TTP
studies had unreported or low participation
rates (Buck et al. 2004), opening the door for
selection biases. We also doubt that these
“super pregnancy planners,” who program
their pregnancy attempts months ahead, are
representative of the general population. For
example, detailed prospective TTP studies
have sometimes included couples with
higher-than-average educational level (Wilcox
et al. 1988) or those who use natural family
planning methods not widely used (Dunson
et al. 2002). These characteristics may be
associated with the probability of pregnancy
and with the environmental exposures of
interest, thus resulting in possible biases.
These limitations of the prospective
approach do not justify a preference for
retrospective studies. As pointed out by
Tingen et al. (2004), the exclusion of infer-
tile couples in most retrospective studies is
indeed of particular concern; it reduces sta-
tistical power and leads to underestimation
of the effect of the environmental exposure
of interest (Slama et al. 2004).
The current duration approach, another
approach not mentioned by Tingen et al.
(2004), makes it possible to include infertile
couples without resorting to detailed prospec-
tive studies. The current duration approach
relies on the inclusion of couples currently
trying to conceive or who are having inter-
course without contraception (Keiding et al.
2002; Olsen and Andersen 1999). The
recruited couples are asked how long they
have been having unprotected sexual inter-
course. Follow-up of these couples is not
required (Keiding et al. 2002), but it is possi-
ble to obtain information on the occurrence
of a pregnancy. In this case, the approach is
based on principles from the case–cohort
design (Olsen and Andersen 1999).
In the current duration approach, data
on the frequency of sexual intercourse, the
duration of the menstrual cycle during the
attempt at pregnancy, and environmental
exposures can be collected with virtually no
recall bias. The collection of urine or other
biologic samples is possible, at least from the
date of inclusion; that is, some time after ces-
sation of contraceptive use. The advantage of
the current duration approach is that the
inclusion criterion (currently having sexual
intercourse without contraception) is more
clear-cut than that of the prospective
approach. This approach thus has a clearly
defined sampling frame. We are currently test-
ing this approach on a representative popula-
tion of French women 18–45 years of age. 
The four approaches to assessing TTP
are based on different inclusion schemes.
The retrospective approach is based on the
inclusion of couples who already had a preg-
nancy; prospective approaches (detailed and
not) are most often based on the inclusion of
couples who will soon discontinue contra-
ceptive use; and the current duration
approach is based on the inclusion of couples
currently trying to conceive. We believe that
none of these methods can currently be con-
sidered a gold standard. In particular, unlike
Tingen et al. (2004), we do not think that
the potential bias from the exclusion of preg-
nancies occurring during contraceptive use
(Baird et al. 1994) is specific to the retro-
spective approach, because prospective (and
current duration) studies seldom include
couples using contraceptive methods.
Instead, we believe that the existence of
new, alternative approaches should provoke
comparative studies, leaving room for debate
before conclusions are drawn about which
approach is preferable for a given purpose.
The authors declare they have no competing
financial interests.
Rémy Slama 
Béatrice Ducot
INSERM and INED
(French National Institute for Health and
Medical Research and the French National
Institute for Demographic Studies)
Unit 569
Le Kremlin-Bicêtre, France
E-mail: slama@vjf.inserm.fr
Niels Keiding
Department of Biostatistics
University of Copenhagen
Copenhagen, Denmark
Jean Bouyer
INSERM and INED
(French National Institute for Health and
Medical Research and the French National
Institute for Demographic Studies)
Unit 569
Le Kremlin-Bicêtre, France
REFERENCES
Baird DD, Weinberg CR, Schwingl P, Wilcox AJ. 1994.
Selection bias associated with contraceptive practice in
time-to-pregnancy studies. Ann NY Acad Sci 709:156–164. 
Buck GM, Lynch CD, Stanford JB, Sweeney AM, Schieve LA,
Rockett JC, et al. 2004. Prospective pregnancy study
designs for assessing reproductive and developmental
toxicants. Environ Health Perspect 112:79–86. 
Dunson DB, Colombo B, Baird DD. 2002. Changes with age in
the level and duration of fertility in the menstrual cycle.
Hum Reprod 17:1399–1403. 
Keiding N, Kvist K, Hartvig H, Tvede M, Juul S. 2002.
Estimating time to pregnancy from current durations in a
cross-sectional sample. Biostatistics 3:565–578. 
Olsen J, Andersen PK. 1999. We should monitor human
fecundity, but how? A suggestion for a new method that
may also be used to identify determinants of low fecun-
dity. Epidemiology 10:419–421. 
Slama R, Jensen TK, Scheike T, Ducot B, Spira A, Keiding N.
2004. How would a decline in sperm concentration over
time influence the probability of pregnancy? Epidemiology
15:458–465.
Tingen C, Stanford JB, Dunson DB. 2004. Methodologic and
statistical approaches to studying human fertility and
environmental exposure. Environ Health Perspect
112:87–93. 
Wilcox AJ, Weinberg CR, O’Connor JF, Baird DD, Schlatterer JP,
Canfield RE, et al. 1988. Incidence of early loss of preg-
nancy. N Engl J Med 319:189–194.
Studying Human Fertility
We very much welcome the National
Children’s Study, which promises to raise
the study of factors affecting reproduction
and development to a new level. An impres-
sive and exciting range of new methodologies
is being developed (Chapin and Buck 2004;
National Children’s Study 2004). 
However, we think it important to cor-
rect some of the inaccurate statements con-
cerning the use of retrospective time to
pregnancy (TTP) made by Tingen et al.
(2004). We do not see prospective methods
and the retrospective approach as alternatives;
they are complementary, each having their
strengths and weaknesses. Unfortunately,
Tingen et al. presented a negative and dis-
torted view of retrospective TTP studies,
describing things that are “often” or “typi-
cally” done but that do not represent current
best practice; then they used their description
to denigrate all such studies. Although it is
true that retrospective studies are subject to
multiple potential “bias in recruitment, recall,
and behavior or exposure trends” (Tingen
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et al. 2004), careful sampling and question-
naire design and use of appropriate methods
of analysis can address most of these issues. 
Retrospective studies are not necessarily
pregnancy based. They can be conducted in
random population-based samples and fre-
quently are cross-sectional or birth cohort
studies (Joffe 2000; Joffe and Li 1994;
Karmaus et al. 1999; Sallmén et al. 1995;
Schaumburg and Boldsen 1992; Schaumburg
and Olsen 1989; Thonneau et al. 1999),
thereby overcoming the problem that only
women who eventually conceived are
included. Even in pregnancy-based studies, if
there are concerns about differential prenatal
care (an issue in the United States but not in
western Europe, for example), recruitment
could be based on births rather than pregnan-
cies, obviously with loss of nonbirth out-
comes. If sampling is population based, it is
feasible to ascertain periods of unprotected
intercourse not leading to conception (gener-
ally stipulating a minimum duration such as
6 months); these attempts can be added to
the pregnancy-related TTP values to generate
the “time of unprotected intercourse”
(Karmaus et al. 1999). 
Tingen et al. (2004) presented simple
issues of questionnaire design negatively, but
these problems can be easily solved. For
example, if data are collected in relation to
the starting time instead of the conception
time (Weinberg et al. 1994), behavior
change does not lead to bias but only to
nondifferential loss of information. 
A central issue is planning bias, the
question being how to exclude accidental
(unplanned) pregnancies without bias
occurring if the exposure variable is asso-
ciated with the degree of “plannedness.”
Retrospective studies can readily investigate
this by following the standard guidance to
collect full information for all pregnancies,
including all covariates, and carry out parallel
analyses with “unplanned pregnancy rate” as
outcome variable (Weinberg et al. 1994).
Prospective studies are unable to do this
because only planners are recruited. 
Tingen et al. (2004) stated that in TTP
studies, “women are asked to recount their
contraceptive and sexual history.” This is
incorrect; in TTP studies, women are not
asked for this detailed information because
it would be invasive and inaccurate. Instead,
women are simply asked how long it took to
conceive, a question that is acceptable and
that most can answer. The replies give an
accurate representation of the true TTP dis-
tribution (Baird et al. 1991; Joffe et al.
1993, 1995; Zielhuis et al. 1992), even with
recall of up to 20 years (Joffe et al. 1995).
Although digit preference (and other non-
differential misclassification) can occur, the
implication is that more respondents are
required than would be the case with perfect
information. Nevertheless, stable estimates
of the TTP distribution can be obtained
with approximately 200 values in each expo-
sure group, or fewer in the case of ordered
categories such as successive 5-year periods
(Joffe 2000). 
We agree that a major limitation of
retrospective studies is that it is impossible to
obtain detailed, timed information on expo-
sures and key biologic events such as ovula-
tion, and difficult to ascertain certain
covariates such as frequency or timing of
intercourse. This is the key strength of the
prospective design. On the other hand, retro-
spective studies are representative because, as
already noted, sampling from the general
population is available and planning bias can
be handled. The questions are easily admin-
istered and answered, and the response rate is
high. Even response bias can be avoided by
nesting the TTP questions within a more
general population survey, thus decoupling
survey nonresponse from differential fertility
or other motivation that would convert low
response rates to response bias (Joffe 2000).
Selection bias remains a potential problem
for some retrospective designs but can be
handled by appropriate statistical analysis
allowing for truncation effects (Scheike and
Jensen 1997). 
Not only are prospective studies time-
consuming and costly, and therefore likely
to be rarely used, but they have important
methodologic drawbacks. For example, it is
impossible to distinguish the approximately
3% of couples who are sterile from those
who merely take a long time to conceive
(> 10% typically take > 12 months), unless
follow-up is extremely long. 
More seriously, prospective studies are
dominated by the lack of a sampling frame
(except in occupational studies) and by a
potent combination of planning bias and
response bias. They can include only couples
who deliberately plan and are willing to vol-
unteer for onerous monitoring. This is
acceptable for internal comparisons (e.g.,
studying day-specific conception rates, each
subject being her own control) but raises
serious problems with external validity.
Tingen et al. (2004) referred to this only in
their Table 1—“Participants might be less
representative of target population”—but
not in the text; in contrast, Buck et al.
(2004) admitted that women who plan their
pregnancies may be systematically different
from those who do not, that this may
adversely affect external validity to a degree
which cannot be empirically evaluated, and
that the findings may not be generalizable to
all women. 
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Studying Human Fertility:
Response to Slama et al. and
Joffe et al.
Slama et al. provide valuable comments on
sampling frames to study fecundity, and we
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agree that the sampling frame is a major
methodologic problem in fecundity studies of
all designs. The current duration strategy of
enrolling couples currently attempting preg-
nancy is a promising approach, particularly
when couples are followed after enrollment
to obtain detailed prospective information.
Data from the menstrual cycles before enroll-
ment can then be combined with detailed
data from cycles during the study period
using recently proposed statistical methods
(Dunson 2003).
However, it is important to note that this
innovative combination of retrospective and
prospective designs still does not address the
vexing problem of couples who do not have
a clearly defined pregnancy attempt.
Demographic surveys and qualitative
research reveal that many—perhaps most—
pregnancies are not exactly planned in the
sense of an exactly defined onset of intention
to become pregnant (Trussell et al. 1999).
Even the onset of sexual intercourse without
contraception may not always be easy to
define reliably, with periods of use inter-
spersed with periods of nonuse. Ultimately, a
complete evaluation of this issue will need to
include couples using contraception, at least
at study enrollment. Some studies have done
this, at least for barrier contraceptives
(Eskenazi et al. 1995).
Joffe et al. comment on alternative retro-
spective designs that can be considered to
address the problem of a nonrepresentative
sample. We agree that prospective studies
are limited by the fact that individuals will-
ing to participate may not be representative
of the general population (as in prospective
epidemiologic studies of other heath out-
comes). However, many of Joffe et al.’s
comments on the prospective design are
unduly negative. For example, the stated
methodologic problem of it being “impossi-
ble to distinguish the approximately 3% of
couples who are sterile from those who
merely take a long time to conceive” is not
specific to the prospective design, but a gen-
eral issue in distinguishing sterility from
infertility in the absence of known causes of
sterility (Dunson et al. 2004). 
The “best” design (if it exists) really
depends on the scientific questions of 
interest. Retrospective and population-based
studies have an important role in assessing
population fecundability in demographic
studies, in studying effective fecundability,
and in surveillance for possibly significant
environmental exposures. However, our
focus is on studies investigating the poten-
tially complex and time-varying effects of
environmental exposures on biologic
fecundability. Intercourse timing relative to
ovulation has a critical role, not only in
determining the overall probability of 
conception in a menstrual cycle, and hence
time to pregnancy, but also in predicting
later outcomes, such as early pregnancy loss
(Wilcox et al. 1998). Confounding resulting
from differences in exposed and unexposed
individuals in their sexual behavior, includ-
ing timing and frequency of intercourse, is a
major concern. There can be problems even
if the individuals have the same intercourse
frequency because there is substantial vari-
ability in the timing of ovulation (Wilcox
et al. 2000). In addition, prospective data on
mucus and hormones potentially provide
important information about biologic
mechanisms. 
For all of these reasons, we continue to
recommend that whenever possible, detailed
prospective data of the type that we have
outlined should be collected in epidemio-
logic studies of fecundity, as well as in studies
that seek to relate periconception exposures
to later reproductive and developmental out-
comes. Daily sampling of urine (via samples
sent to the laboratory, or onsite with com-
mercially available computerized devices) is
one way to achieve this, but not the only
one. We detailed other currently available
and feasible approaches in our article
(Tingen et al. 2004).
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The WTC Disaster and
Asbestos Regulations
Landrigan et al. (2004) reported on exposure
to asbestos as a result of events involving the
World Trade Center (WTC). Their results
are somewhat lower than that reported by
others (Lange 2004) for this unfortunate
event. I reported a single asbestos bulk sam-
ple at 40% asbestos (Lange 2004), although
Landrigan et al. suggested that most are in
the range of 1–3%. Because there was one
“high” bulk sample observed, it is likely that
numerous other locations had similar “ele-
vated” asbestos levels. Airborne exposures
were also elevated for a considerable time
period after the event (Lange 2004). Although
measurements were reported as task-length
averages (TLA), it is likely that some per-
sonal samples (Lange 2004) exceeded the
U.S. Occupational Safety and Health
Administration permissible exposure limit
(PEL) of 0.1 fibers/cm3 well after the first
few days of the event. For example, during
1 January 2002–11 February 2002 in the west
area, the arithmetic mean exposure and an
upper reported value (0.500 fibers/cm3-TLA)
were above the PEL (Lange 2004). 
Landrigan et al. (2004) also reported
clearance samples as fibers per millimeter
squared, which likely should be in struc-
tures per millimeter squared. It should be
noted that this clearance standard has not
been shown to be health based, and struc-
tures per millimeter squared cannot be
equilibrated or converted to fibers per milli-
meter squared.
Even with evidence of higher exposure
levels, on the basis of reported data (Lange
2004), it is unlikely that exposure to
asbestos itself will result in any actual health
effects. This is because the asbestos was
mostly chrysotile (Landrigan et al. 2004)
and the duration of exposure for most
workers was short (Lange 2003). However,
as previously reported (Lange 2001, 2002,
2004), regulatory agencies ignored their
own regulations at the WTC, whereas
asbestos concentrations (bulk and air) for
other locations would probably trigger a
regulatory response and most likely a cita-
tion with a requirement of some action
plan. Thus, it appears that there are two
standards to be taken from the WTC, one
for agencies themselves and another for all
others. 
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The WTC Disaster: Landrigan’s
Response
My colleagues and I thank Lange for his let-
ter confirming our finding that asbestos was
present in settled dust as well as in airborne
samples obtained at Ground Zero, the site of
the World Trade Center, and for his having
agreed with us that this asbestos almost cer-
tainly represented an exposure hazard for
workers. The asbestos that was detected in
the dust at Ground Zero originated from
asbestos that had been sprayed onto the steel
skeleton of the Twin Towers as fireproofing
when the structure was being built. It was
well known that asbestos was applied in the
North Tower up to about the 40th story and
at other locations throughout the structure
before the practice of spraying on asbestos
was banned in New York City in the early
1970s (Nicholson et al. 1971; Reitze et al.
1972). Concentrations of asbestos in the dust
at Ground Zero were highly variable, and the
level in any particular sample reflects the
location of sampling and the composition of
the dust that happened to be in that area. We
agree with Lange’s view that workers likely
had intermittent exposures to asbestos that
would have arisen unpredictably when, for
example, they picked up a steel beam or
turned over rubble and liberated asbestos
fibers into the air. The asbestos hazard to
workers was magnified by the fact that the
U.S. Occupational Safety and Health
Administration (OSHA) failed to require
constant use of respirators at Ground Zero.
We disagree strongly with Lange’s state-
ment that “it is unlikely that exposure to
asbestos itself will result in any actual health
effects.” Lange appears to base his assertion,
first, on the fact that most of the asbestos at
the World Trade Center was chrysotile
asbestos, and second, that duration of
exposure for most workers was brief.
Unfortunately neither of those factors con-
veys protection. We remain concerned that
there now exists a risk for mesothelioma
caused by occupational exposure to asbestos
for the brave men and women who worked
and volunteered at Ground Zero.
All types of asbestos fibers, chrysotile
included, have been shown in laboratory as
well as clinical studies to be capable of caus-
ing malignant mesothelioma (Nicholson
and Landrigan 1996). All types of asbestos
fibers, chrysotile included, have been
declared proven human carcinogens by
OSHA, the U.S. Environmental Protection
Agency, and the International Agency for
Research on Cancer. Pathologic studies have
found short chrysotile fibers, the predomi-
nant type of fiber in World Trade Center
dust, to be the predominant fiber in
mesothelioma tissue (Dodson et al. 1991;
LeBouffant et al. 1973; Suzuki and Yuen
2002). Moreover, mesothelioma has been
reported in persons with relatively low-dose,
nonoccupational exposure to asbestos of
brief duration (Anderson 1982; Camus et al.
1998; Magnani et al. 2001). The greatest
future risk of mesothelioma would appear to
exist among first responders who were cov-
ered by the cloud of dust on 11 September
2001 as well as in other workers employed
directly at Ground Zero and workers
employed in cleaning asbestos-laden dust
from contaminated buildings. Although we
agree with Lange that the number of
mesothelioma cases will probably not be
great, we think it quite misleading to state
that no risk exists.
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Trichloroethylene and Cardiac
Malformations
In a report of cardiac malformations in rats
exposed to trichloroethylene (TCE) in drink-
ing water, Johnson et al. (2003) used two
(1.5 and 1,100 ppm) of the four treatment
concentrations that they reported in a previ-
ous study (Dawson et al. 1993). To evaluate
consistency of results in this single laboratory
across the 10-year interval, we compared car-
diac defects reported in 2003 by Johnson
et al. with those reported in 1993 by Dawson
et al. Data from the two papers are shown in
Table 1.
Dawson et al. (1993) did not report the
number of litters per group, so that correla-
tion was not possible. Regardless, it would be
an astonishing coincidence for two studies to
produce exactly the same number of fetuses
in each group. Still more astonishing is the
identical number of “abnormal hearts.”
Nothing reported by Johnson et al. (2003)
gives notice that previously published data
are being reported again, but that seems to
be the inescapable conclusion. If this is a
republication of 1993 data, then there has
also been reclassification of “defects” with the
passage of time.
Another feature of the article by Johnson
et al. (2003) that attracted our attention was
the uncharacteristically large control group
(55 litters). One can surmise that in the ear-
lier study (Dawson et al. 1993), each group
would have consisted of approximately
10 females, which is consistent with the size
of exposed groups (9–13) reported by
Johnson et al. Their control group, however,
was unprecedentedly large, both in the con-
text of conventional study design and relative
to the other groups in this study. Johnson et
al. (2003) provided no rationale for designing
their study with a concurrent control five
times larger than the treatment groups, which
leads us to ask whether the control group
reported here is, in fact, a composite of con-
trols from multiple, perhaps five, different
studies. The immediate impact of this large
control group is that the very cardiac “abnor-
malities” at the 1.5 ppm dose that did not
differ significantly from controls in 1993
become statistically significant in 2003.
Conventional developmental and repro-
ductive toxicology assays in mice, rats, and
rabbits consistently fail to find adverse effects
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of TCE on fertility or embryonic develop-
ment aside from embryo- or fetotoxicity
associated with maternal toxicity [Cosby and
Dukelow 1992; Dorfmueller et al. 1979;
Hardin et al. 1981; Healy et al. 1982;
Manson et al. 1984; National Toxicology
Program (NTP) 1985, 1986; Schwetz et al.
1975]. Johnson and Dawson, with their col-
laborators, are alone in reporting that TCE is
a “specific” cardiac teratogen (Dawson et al.
1990, 1993; Goldberg et al. 1992; Johnson
et al. 1998; Johnson et al. 2003; Loeber et al.
1988). We have always considered those
findings suspect, and our comparison of data
from the studies of Dawson et al. (1993) and
Johnson et al. (2003) serves only to intensify
our reservations. Studies from this group
have potential for important public health
and public policy implications, so it is partic-
ularly important for the scientific and regula-
tory communities to have confidence in the
conduct and reporting of those studies. 
We are also concerned that S.J. Goldberg,
one of the authors of the publications alleging
that TCE is a selective cardiac teratogen, has
been a plaintiff expert in TCE lawsuits and
failed to reveal that fact in his publications.
B.D.H. has had no consulting relationships
involving TCE. B.J.K. has provided testimony as
a defense expert in TCE litigation pertaining to
congenital malformations. R.L.B. has provided
testimony as a defense expert in TCE litigation
pertaining to congenital malformations of the
heart. 
Bryan D. Hardin
GlobalTox, Inc.
Hilton Head, South Carolina
E-mail: bhardin@globaltox.com
Bruce J. Kelman
GlobalTox, Inc.
Redmond, Washington
Robert L. Brent
Alfred I. DuPont Institute
Wilmington, Delaware
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Trichloroethylene: Johnson
et al.’s Response 
We share Hardin et al.’s belief that any
apparent conflict of interest should be
reported. We note that Brent provided testi-
mony for the defense in TCE litigation,
notably for the same case in which Goldberg
(based on his extensive epidemiologic and
laboratory research on the effects of TCE)
acted as an expert witness for the plaintiff.
We did not report Goldberg’s experience
acting as an expert witness because the point
of expert witness is to provide unbiased, fac-
tual explanations of extant data. We believe
this does not constitute a conflict of interest;
we have included a caveat about extrapolat-
ing data to humans in our publications. To
our knowledge none of our data have been
used inappropriately.
The work published in 1993 (Dawson
et al.) and in 2003 (Johnson et al.) was actu-
ally performed during a much shorter period
of time. Many extraneous factors contributed
to the late publication of the 2003 paper.
Data from our previous work was included
in the more recent paper because we needed
“boundary values” between or below which
we were looking for a threshold or a critical
level. This was a long-term study, and it
would have been an inappropriate use of ani-
mals to repeat the earlier animal studies for
those groups. We should have stated more
clearly that we were using the groups already
studied to prevent repetition and to conserve
animal resources, as recommended by the
Animal Welfare Act (1990); however, we did
refer to our previous paper. Our 2003 publi-
cation contained new data as well as previ-
ously published data. We welcome this
opportunity to clarify our method.
Our alleged reclassification of defects in
our Table 2 (Johnson et al. 2003) merely
reflects careful reevaluation by the cardiolo-
gist and minor updates in terminology that
mirror current clinical usage to clarify the
nature of a defect (e.g., great vessel defect vs.
the more specific aortic hypoplasia; L-trans-
position vs. abnormal looping, etc.). There
are other minor numerical differences in the
tables (Table 2, Johnson et al. 2003, and
Tables 1 and 3, Dawson et al. 1993), not
remarked upon by Hardin et al., which
derive from the more extensive statistical
analysis in the later paper. In an apparent
typographic error, we failed to report a pul-
monary valve defect for the 1.5 ppm TCE
in the 2003 paper. This should have been
included in Table 2; however, it would not
have changed the number of hearts with
defects. 
Again, because this was a long-term con-
tinuous project, we did use all of the controls
together in a cumulative manner. We used
the larger sample size with data collected
over a long period because it increases the
generalizeability of our data, demonstrating
clearly the background rate and the variabil-
ity around rate estimates. Control values
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Table 1. Cardiac malformations in rats exposed throughout pregnancy to drinking water containing 1.5 or
1,100 ppm TCE.
Cardiac abnormalitiesa TCE dose Heart malformationsb TCE dose
(Dawson et al. 1993) 1.5 ppm 1,100 ppm (Johnson et al. 2003) 1.5 ppm 1,100 ppm
L-Transposition (left chest) 1 0 Abnormal looping 2 0
Great vessel defect 1 0 Aortic hypoplasia 1 0
Pulmonary valve defect 1 0 Pulmonary artery hypoplasia 1 0
Atrial septal defect 4 7 Atrial septal defect 4 7
Ventricular septal defects Ventricular septal defects
Subaortic 2 1 Perimembranous (subaortic) 3 3
Muscular 1 4 Muscular 1 1
Endocardial cushion defect 0 1 Atrioventricular septal defect 0 1
Aortic valve defect 0 2 Aortic valve defect 0 2
No. with abnormal hearts 9 11 9 11
No. fetuses examined 181 105 181 105
aData from Dawson et al. (1993) Tables 1 and 3, Groups III and IV. bData from Johnson et al. (2003) Table 2; percentage
was converted to number.Correspondence
were consistent throughout our studies. The
larger sample size did increase statistical
power somewhat in our most recent paper
(Johnson et al. 2003), again without inap-
propriate use of further valuable animal
resources. It should be noted that the
increase in statistical power is small com-
pared to the increase generated by the effect
sizes and the increase in the number of dose
groups—data that can only be generated in a
long-term project.
Our statistical analysis was simple and
conventional. Hardin et al. are incorrect in
stating that the differences at the 1.5-ppm
dose were statistically significant in our
recent paper (Johnson et al. 2003). The
p-values were reported in Figures 1 and 2 of
our paper as 0.14 and 0.08, respectively, val-
ues not conventionally seen as statistically
significant. Different levels of statistical sig-
nificance used in each of the studies for each
of the groups were carefully listed in the
tables and figures and explained in the text.
There are many references in the scien-
tific literature about effects of halogenated
hydrocarbons on development. We included
only a few of these in our articles. We are a
multidisciplinary team and have studied
both TCE and its major metabolites, often
basing some of our work on the findings of
others in the field without duplicating the
work of others. We have consulted with
other prominent researchers in the field
from time to time in establishing our experi-
mental design or in interpreting our results.
We have found only heart defects associated
with these compounds, despite looking for
other effects. This work has been consistent
with the original epidemiological studies on
which our laboratory work was based. We
have been funded by government and other
nonbiased agencies requiring competitive
grant application and accountability. We
have presented our results as peer-reviewed
published articles in excellent journals. Our
work has all been carried out at The
University of Arizona. A major strength of
our studies was microdissection of each
heart by investigators fully versed in the
pathology of congenital cardiac malforma-
tions as well as noncardiac anatomy.
We fully agree with Hardin et al. that
studies in this area “have potential for impor-
tant health and public policy implications, so
it is particularly important for the scientific
and regulatory communities to have confi-
dence in the conduct and reporting of those
studies.” We believe that our studies have
been rationally planned, are statistically and
scientifically sound, and are of value for this
purpose. We welcome this opportunity for
postpublication discussion of results.
The authors declare they have no competing
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testimony to be a competing financial interest.
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